Characteristics and psychosocial predictors of psychiatric emergency center transport and length of stay in patients with dementia and Alzheimers disease: A preliminary report

Journal of Psychiatric Practice

Volumn 17, Issue 4, 2011, Pages 251-257

  Nejtek, Vicki A ^a   Hardy, Sarah ^a   Hall, James R ^a   Winter, A Scott ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

aggression; Alzheimers disease; dementia; psychiatric emergency utilization

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZATROPINE; CHOLINESTERASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; SEDATIVE AGENT;

ADULT; AGED; AGGRESSION; AGITATION; ALZHEIMER DISEASE; ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DEMENTIA; EMERGENCY HEALTH SERVICE; FEMALE; GLOBAL ASSESSMENT OF FUNCTIONING; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; NURSING HOME; OFF LABEL DRUG USE; PSYCHOSOCIAL WITHDRAWAL; RETROSPECTIVE STUDY; SOCIAL INTERACTION;

ADAPTATION, PSYCHOLOGICAL; ADULT; AGED; AGED, 80 AND OVER; AGGRESSION; ALZHEIMER DISEASE; EMERGENCY SERVICES, PSYCHIATRIC; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; NURSING HOMES; PATIENT TRANSFER; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 80051741298     PISSN: 15274160     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pra.0000400262.45290.66     Document Type: Article

References (18)

1. Prince M. Epidemiology of Alzheimers. Psychiatry 2004;3:11-13.
2. Ballard CG, Gauthier S, Cummings JL, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol 2009;5:245-55.
3. Kunik ME, Snow AL, Davila JA, et al. Consequences of aggressive behavior in patients with dementia. J Neurolo - psychiatry Clin Neurosci 2010;22:40-7.
4. Caffrey C. Potentially preventable emergency department visits by nursing home residents: United States, 2004. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, NCHS Data Brief, 2010 Apr 33:1-8.
5. Ouslander JG, Lamb G, Perloe M, et al. Potentially avoidable hospitalizations of nursing home residents: Frequency, causes, and costs. J Am Geriatr Soc. 2010;58: 627-35.
6. Whall AL, Colling KB, Kolanowki A, et al. Factors associated with aggressive behavior among nursing home residents with dementia. Gerontologist 2008;48:721-31.
7. Allen-Burge R, Stevens AB, Burgio LD. Effective behavioral interventions for decreasing dementia-related challenging behavior in nursing homes. Int J Geriatr Psychiatry 1999;14:213-32. (Pubitemid 29142150)
8. Volicer L, Van der Steen JT, Frijters DHM. Modifiable factors related to abusive behaviors in nursing home residents with dementia. J Am Med Dir Assoc 2009;10: 617-22.
9. Beck C, Ortigara A, Mercer S, et al. Enabling and empowering certified nursing assistants for quality dementia care. Int J Geriatr Psychiatry 1999;14:197-212. (Pubitemid 29142149)
10. Leonard R, Tinneti ME, Allore HG, et al. Potentially modifiable resident characteristics that are associated with physical or verbal aggression among nursing home residents with dementia. Arch Intern Med 2006;166: 1295-300. (Pubitemid 43967582)
11. American Psychiatric Association. Global Assessment of Functioning scale. In: Diagnostic and statistical manual of mental disorders, 4th edition, text revision. Washington, DC: American Psychiatric Association; 2000:32-4.
12. City-data website (available at www.city-data.com/zips, accessed March 31, 2011).
13. Gentile S. Second-generation antipsychotics in dementia: Beyond safety concerns. A clinical systematic review of efficacy data from randomized controlled trials. Psycho - pharmacology (Berl) 2010; 212:119-29.
14. Ballard C, Corbett A. Management of neuropsychiatric symptoms in people with dementia. CNS Drugs 2010;24: 729-39.
15. Schneider LS, Dagerman K, Insel PS. Efficacy and adverse effects of atypical antipsychotics for dementia: Metaanalysis of randomized, placebo-controlled trials. Am J Geriatr Psychiatry 2006;14:191-210.
16. Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimers disease. Cochrane Database Syst Rev 2006;25(1):CD003476.
17. Miller LJ. The use of cognitive enhancers in behavioral disturbances of Alzheimers disease. Consult Pharm 2007;22:754-62. (Pubitemid 47438723)
18. Grossberg GT, Pejović V, Miller ML, et al. Memantine therapy of behavioral symptoms in community-dwelling patients with moderate to severe Alzheimers disease. Dement Geriatr Cogn Disord 2009; 27:164-72.